China Pharma Holdings Total Liabilities 2010-2025 | CPHI
China Pharma Holdings total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
China Pharma Holdings Annual Total Liabilities
(Millions of US $) |
| 2024 |
$7 |
| 2023 |
$9 |
| 2022 |
$13 |
| 2021 |
$17 |
| 2020 |
$13 |
| 2019 |
$13 |
| 2018 |
$15 |
| 2017 |
$17 |
| 2016 |
$20 |
| 2015 |
$24 |
| 2014 |
$28 |
| 2013 |
$25 |
| 2012 |
$15 |
| 2011 |
$14 |
| 2010 |
$14 |
| 2009 |
$13 |
China Pharma Holdings Quarterly Total Liabilities
(Millions of US $) |
| 2025-03-31 |
$7 |
| 2024-12-31 |
$7 |
| 2024-09-30 |
$7 |
| 2024-06-30 |
$7 |
| 2024-03-31 |
$8 |
| 2023-12-31 |
$9 |
| 2023-09-30 |
$9 |
| 2023-06-30 |
$11 |
| 2023-03-31 |
$13 |
| 2022-12-31 |
$13 |
| 2022-09-30 |
$13 |
| 2022-06-30 |
$14 |
| 2022-03-31 |
$16 |
| 2021-12-31 |
$17 |
| 2021-09-30 |
$11 |
| 2021-06-30 |
$13 |
| 2021-03-31 |
$13 |
| 2020-12-31 |
$13 |
| 2020-09-30 |
$13 |
| 2020-06-30 |
$15 |
| 2020-03-31 |
$14 |
| 2019-12-31 |
$13 |
| 2019-09-30 |
$13 |
| 2019-06-30 |
$14 |
| 2019-03-31 |
$15 |
| 2018-12-31 |
$15 |
| 2018-09-30 |
$15 |
| 2018-06-30 |
$17 |
| 2018-03-31 |
$18 |
| 2017-12-31 |
$17 |
| 2017-09-30 |
$18 |
| 2017-06-30 |
$20 |
| 2017-03-31 |
$20 |
| 2016-12-31 |
$20 |
| 2016-09-30 |
$22 |
| 2016-06-30 |
$25 |
| 2016-03-31 |
$25 |
| 2015-12-31 |
$24 |
| 2015-09-30 |
$28 |
| 2015-06-30 |
$26 |
| 2015-03-31 |
$30 |
| 2014-12-31 |
$28 |
| 2014-09-30 |
$26 |
| 2014-06-30 |
$25 |
| 2014-03-31 |
$25 |
| 2013-12-31 |
$25 |
| 2013-09-30 |
$20 |
| 2013-06-30 |
$15 |
| 2013-03-31 |
$13 |
| 2012-12-31 |
$15 |
| 2012-09-30 |
$17 |
| 2012-06-30 |
$17 |
| 2012-03-31 |
$17 |
| 2011-12-31 |
$14 |
| 2011-09-30 |
$13 |
| 2011-06-30 |
$12 |
| 2011-03-31 |
$13 |
| 2010-12-31 |
$14 |
| 2010-09-30 |
$11 |
| 2010-06-30 |
$13 |
| 2010-03-31 |
$11 |
| 2009-12-31 |
$13 |
| 2009-09-30 |
$10 |
| 2009-06-30 |
$8 |
| 2009-03-31 |
$7 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.007B |
$0.005B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
